SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Trinity Bio-Tech Ltd (530573) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 530573 NSE: | Finance - NBFC | Small Cap

BSE Share Price
Not Listed

Trinity Bio-Tech Ltd (530573)

BSE: 530573 NSE:
Key Metrics
Market Cap
₹1 Cr.
Earnings Per Share (TTM)
₹0.07
P/E Ratio
53.91
Price to Book (P/B)
9.38
EV/EBITDA
432.66
Current Price
₹0
Return on Capital Employed (ROCE)
0.36%
Return on Equity (ROE)
0.00%
Return on Assets (ROA)
0.36%
Gross NPA(%)
0.00
Book Value per Share
₹0.4
Net NPA(%)
0.00
Dividend Yield
0.00%
Net Interest Income Growth (1 Year)
100%
Net Interest Income Growth (3 Years)
NA%
52-Week Low / High
₹0 / 0
Book Value Growth (1 Year)
NA%
Book Value Growth (3 Years)
NA%

DeciZen - make an informed investing decision on Trinity Bio-Tech

Based on:

M-Cap below 100cr DeciZen not available

Trinity Bio-Tech stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Operating Income (₹ Cr.)0.100000-0.50.2000
YoY Gr. Rt. %--63.6%0%-100%NANANANA-91.7%100%-
Adj EPS (₹ ) 0.30.7-0.5-5.4-0.10-1.90.4-00.10.1
YoY Gr. Rt. %-192%-169.9%NANANA-6333.3%NA-110%NA-
BVPS (₹ )-0.10.60.1-5.3-5.3-5.3-7.2-6.8-6.8-6.80.4
YoY Gr. Rt. %-NA-82.3%-4890.9%NANANANANANA-
To view Net Profit/Total Funds (%) Colour Rating Guide click here
Net Profit/Total Funds (%)0.61.6-1.1-12.7-0.20.1-8.22.2-0.20.40

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Net Interest Income-10.6%NANA100%
Adj EPS-13.2%NANANA
BVPSNANANANA
Share Price - - - -

Key Financial Ratios

RATIOS \ YEARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Asset Quality Ratio To view Asset Quality Ratio Colour Rating Guide click here
Net NPA to Net Advances (%)0000000000-
Capitalization Ratio To view Capitalization Ratio Colour Rating Guide click here
Capital Adequacy Ratio (%) 0000000000-
Margins
Net Profit Margin (%)78.7576.8-385.900011956.5-7657.358.3
Performance Ratios To view Performance Ratios Colour Rating Guide click here
Return on Equity (%)0283.8-140.100000007.1

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹) 0.4 -
Reserves (₹ Cr.) -3 -
P/BV 9.38 -
PE 53.91 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 1.04 / 50.00
Market Cap (₹ Cr.) 1.2
Equity (₹ Cr.) 3.3
Face Value (₹) 10
Industry PE 29.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Trinity Bio-Tech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Total Income (Cr.)

ROE (%)

BVPS (Rs.)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Income + 0.370.370.191.443.980.01-0.520.240.020.04
Interest Income0.110.040.04000-0.520.240.020.04
Other Income 0.0400.243.133.8600000
Exceptional Items 0.270.330.141.443.980.010000
Expenditure + 0.290.130.363.23400.100.100.030.02
Interest Expense 0000.04000000
Operating Expenses 0.240.120.120.050.1400.090.100.030.02
Provisions 0.0400.243.133.8600000
Exceptional Items 0000000000
Profit Before Tax 0.080.24-0.17-1.79-0.020.01-0.620.13-0.010.02
Taxes 00000.0100000
Profit After Tax 0.080.24-0.17-1.79-0.020.01-0.620.13-0.010.02
Adjusted EPS (₹)0.30.7-0.5-5.4-0.10.0-1.90.4-0.00.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Equity Capital +-0.040.210.04-1.75-1.78-1.76-2.39-2.25-2.26-2.24
Share Capital 3.333.333.333.333.333.333.333.333.333.33
Reserves -3.36-3.12-3.29-5.08-5.10-5.09-5.71-5.58-5.59-5.57
Short term borrowings0000000000
Long Term Borrowings9.549.9710.2310.1510.8410.818.478.478.488.47
Current Liabilities 5.525.075.693.870.030.080000
Trade Payables0.050.050.050.040.020.080000
Other Liabilities-0.05-0.05-0.05-0.04-0.02-0.08-0-0-00
Total Liabilities 15.0215.2515.9612.269.099.136.096.236.226.24

Assets

Non Current Asset +2.582.472.070.910.920.846.016.156.116.15
Loan Asset 0000000000
Other Non Current Asset 2.582.472.070.910.920.846.016.156.116.15
Current Asset +12.4512.7813.8911.368.178.280.080.080.100.08
Current Investment000000.080000
Other Current Asset12.4512.7813.8911.368.178.210.080.080.100.08
Total Assets 15.0215.2515.9612.269.099.136.096.236.226.24

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'03Mar'04Mar'05Mar'07Mar'10Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity -0.170.63-0.07-0.6200000
Cash Flow From Investing Activity 0.050.01-0.710.3500000
Cash Flow From Financing Activity 0.13-0.650.790.2700000
Net Cash Flow 0.01-0.010.01000000

Finance Ratio

PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14

Operational & Financial Ratios

EPS (₹)01-1-5-00-20-00
DPS (₹)0000000000
BVPS (₹)-010-5-5-5-7-7-7-7

Performance Ratios

ROA (%)0.61.6-1.1-12.7-0.20.1-8.22.2-0.20.4
ROE (%)0.0283.8-140.00.00.00.00.00.00.00.0
ROCE (%)1.02.5-1.7-18.7-0.20.1-8.22.2-0.20.4

Valuation Parameters

Price/Book(x)-32.45.236.10.00.00.00.00.00.00.0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Trinity Bio-Tech Ltd FAQs

The current trading price of Trinity Bio-Tech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Trinity Bio-Tech stood at ₹1.20 Cr

The latest P/E ratio of Trinity Bio-Tech as of 31-Dec-1969 is 53.91.

The latest P/B ratio of Trinity Bio-Tech as of 31-Dec-1969 is 9.38.

The 52-week high of Trinity Bio-Tech is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trinity Bio-Tech is ₹0.04 ( Cr.) .

About Trinity Bio-Tech Ltd

Trinity Bio-Tech Ltd was originally incorporated as a Private Limited Company under the name of Bombay Mangalam Impex Private Limited and received the Certificate of Incorporation dated 8th March, 1998 from the Registrar of Companies, Maharashtra, Bombay. The company was  converted into a Public Limited Company vide Special Resolution passed on  January 28, 1993 and fresh certificate of Incorporation consequent, to change of name was issued by the Registrar of companies, Maharashtra on 11th February, 1993. 

The company was intially engaged in the trading and export activity of raw cotton.  Subsequently, the Company started operations of Hire Purchase, Leasing and also started investment and trading in shares both in  primary and secondary market in its own portfolio.

It operates as a non-banking financial company in India. The company invests in shares and securities; and involves in the hire purchase and leasing activities. It also trades in standing bio-stock, vegetable and crops, mangoes, cashewnuts, and mango pulp. In addition, the company offers software programs.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×